CNL and Partners Identified Three Canadian Locations to Advance the Design of Renewable Diesel Production Facilities
The concept, known as 'e-Syn', encompasses the use of water and water electrolysis as part of an innovative, patented and patent pending process for making bio-synthetic fuels developed by CNL and Expander, called the Biomass Electrolysis to Liquids (BETL™) technology. The project leverages Expander's technology for biomass gasification and bio-synthetic fuel production, and electrolysis technology. The resulting fuel (either bio-synthetic diesel, known as Bio-SynDiesel®, or bio-synthetic aviation fuel, known as Bio-SynJet®) will be comprised entirely of carbon sourced from biogenic (atmospheric) sources, and is expected to have very low life cycle carbon intensity.
As part of the feasibility study, a number of potential sites in Canada were evaluated with the intent of selecting one site for a Front-End Engineering Design (FEED) phase of the project. This process culminated in the selection of three locations at sites in British Columbia, Ontario and Quebec, all of which fulfill the necessary requirements in terms of proximity to utilities, and accessibility to major roads and key resources like biomass, among other factors. Following NRCan's approval, the feed study was extended from one to the three sites, a process that is expected to be completed in the Fall of 2025.
'CNL is thrilled at the results that were generated through the feasibility study and is ready to move into the next phase of the project, which has the potential to eventually produce economical, ready-to-deploy, renewable diesel fuel,' commented Stephen Bushby, CNL's Vice-President of Science and Technology. 'As Canada moves towards a net-zero future, synthetic transportation fuels provide an immediate opportunity for the country to reduce its greenhouse gas emissions, with the additional benefit of leveraging waste, such as wood, that may otherwise go to waste. The transportation sector in Canada is responsible for almost 25 per cent of the country's total emissions, so this innovation has the potential to make an important impact toward decarbonizing that sector, as well as Canada's overall carbon footprint.'
'This is not a science experiment – the feasibility study showed that the BETL™ technology can efficiently produce bio-synthetic fuels at prices competitive with existing food competitive Hydrogenation-Derived Renewable Diesel (HDRD) and Hydroprocessed Esters and Fatty Acids (HEFA) fuels,' commented Gord Crawford, Expander's President and CEO. 'Preliminary economic assessments indicated strong financial performance for all three sites. For future opportunities to actually deploy this technology, Expander and CNL plan to install a commercially proven electrolyzer as part of the planned Expander Carseland Alberta Gasifier project in order to technically and commercially derisk potential investment in the three sites under development in the CFF program.'
The engineering design work will be based on the utilization of 240 dry tonnes of forestry wood waste per day as feedstock to annually produce approximately 30 million liters of renewable diesel per processing facility by using the BETL™ technology. The design of these facilities could also serve as a template for future sites, both nationally and internationally, using a build, own and operate model. Site specific details will be announced in coordination with local partners, including government and Indigenous nations and organizations, in the near future.
The relevance of this project is timely in Canada. While increasing the supply of low-carbon electricity, including nuclear generation and other renewable power options, will be critical to reaching Canada's net zero target, synthetic liquid fuels provide an immediate opportunity to decarbonize marine, aviation and other heavy duty transport sectors using existing engines. These clean fuels are 'drop in' ready, providing an attractive opportunity to decarbonize without the need to make major changes to engine design and manufacturing processes. Converting cellulosic biomass, such as lumber mill and forest residues, to synthetic diesel or sustainable aviation fuel, is also an attractive and promising method to produce fuel that complies with North America's ASTM D975 and Europe's CEN 15940 diesel specifications. Several investors, including major offtakers, have expressed interest in participating in any potential projects.
About CNL
As Canada's premier nuclear science and technology laboratory and working under the direction of Atomic Energy of Canada Limited (AECL), CNL is a world leader in the development of innovative nuclear science and technology products and services. Guided by an ambitious corporate strategy known as Vision 2030, CNL fulfills three strategic priorities of national importance – restoring and protecting the environment, advancing clean energy technologies, and contributing to the health of Canadians.
By leveraging the assets owned by AECL, CNL also serves as the nexus between government, the nuclear industry, the broader private sector and the academic community. CNL works in collaboration with these sectors to advance innovative Canadian products and services towards real-world use, including carbon-free energy, cancer treatments and other therapies, non-proliferation technologies and waste management solutions.
To learn more about CNL, please visit
www.cnl.ca
.
About Expander Energy Inc.
Expander Energy Inc. is a Calgary, Alberta based energy technology company that has developed a patented suite of transportation fuel production technologies to convert biomass and low Carbon Intensity electricity into 'Fossil Free' Low Life Cycle Carbon Intensity synthetic diesel fuel (Bio-SynDiesel®) and synthetic kerosene jet fuel (Bio-SynJet®). Expander's Bio-Energy Carbon Capture and Sequestration (BECCS) solution utilizes cellulosic biomass to produce next generation low CI synthetic fuels while efficiently capturing bio-carbon for geologic sequestration. Bio-SynDiesel®, Bio-SynJet®, BGTL™, EBTL™, BETL™, and CETL™ are trademarks of Expander Energy Inc.
To learn more about Expander, please visit
www.expanderenergy.com
.
About Nuclear Promise X
Nuclear Promise X (NPX) is a forward-thinking Canadian tech start-up, established in 2018, with a mission to transform the nuclear industry through cutting-edge solutions and address the climate crisis. NPX focuses on integrating advanced technology into nuclear plant operations to enhance efficiency, reduce costs, and promote sustainability.
To learn more about Nuclear Promise X, please visit
www.npxinnovation.ca
.
About Fuel Cell Energy Inc.
FuelCell Energy, Inc. is a global leader in sustainable energy technologies that address some of the world's most critical challenges around energy, safety, and global urbanization. It collectively holds 531 fuel cell technology patents in the United States and globally. As a leading global manufacturer of proprietary fuel cell technology platforms, FuelCell Energy is uniquely positioned to serve customers including businesses, utilities, governments, and municipalities with sustainable products and solutions. The company's solutions are designed to enable a world empowered by sustainable energy, enhancing the quality of life for people around the globe.
Learn more at
www.fuelcellenergy.com
.
About St Marys Cement
St Marys Cement is part of Votorantim Cimentos, a global vertically integrated aggregate, cement and concrete solutions provider. With sustainability as a strategic driver, Votorantim Cimentos has committed to ambitious decarbonization goals, including net-zero concrete by 2050 as defined by the GCCA (Global Cement and Concrete Association). As one of its key milestones, the company has set a global 2030 decarbonization target of 475 kg of CO2 per tonne of cement, representing a 24.8% reduction compared to the 2018 baseline year. This target has been approved and verified by the Science Based Target initiative (SBTi). The company works together with industry to reduce emissions and tackle climate change, executing several initiatives simultaneously, including increasing the use of alternative fuels; investing in product innovations with lower clinker content; evaluating carbon capture and utilization technologies; increasing energy efficiency; fostering the circular economy; and participating in the construction of energy-efficient buildings.
To learn more about St Marys Cement, please visit:
www.stmaryscement.com
.
CNL Contact:
Philip Kompass
Director, Corporate Communications
media@cnl.ca
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
ST. PAUL, Minn., Aug. 5, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform. The G-Rex Grant will allow Sidra Medicine to perform the processes and preclinical development for a CD19 CAR-T cell therapy product that will initially be used in pediatric oncology settings. Sidra Medicine will also receive early access to the G-CART™ process currently in development at Cell Ready, the world's first and only G-Rex centric contract development and manufacturing organization (CDMO). The Grant will also support the implementation of fully closed system, semi-automated G-Rex production compliant with current Good Manufacturing Practices (cGMPs). Lastly, the Grant will support the technology transfer to Sidra Medicine's newly established GMP facility for qualification and implementation. "Sidra Medicine is a pioneering healthcare institution that has innovation weaved into the very core of its precision medicine program. Our GMP facility has been specifically set up to develop better treatment protocols for pediatric diseases including cancers, genetic and rare diseases. The G-Rex® Grant will play a key role in accelerating the readiness of our protocols, particularly for Sidra Medicine's pediatric oncology program. Our preliminary findings have already shown us that the G-Rex® method is outstanding in its simplicity and the unique T cell phenotype resulting from the cell culture. This methodology will allow us to implement an affordable, highly efficient G-Rex based cell manufacturing platform with the most suitable T cell phenotype, ultimately having a positive impact on pediatric patient care and cure," said Sara Deola, M.D., Ph.D., Research Investigator at Sidra Medicine. "We're eager to support the emerging Cell & Gene Therapy (CGT) industry in Qatar and the Middle East. By entering the field of CAR-T without any preconceived manufacturing notions and quickly gathering and reviewing G-Rex manufacturing data, Sidra Medicine quickly recognized the full array of advantages that our G-Rex centric manufacturing process offers relative to alternatives. Sidra Medicine's quick grasp of the technical and economic advantages of G-Rex relative to alternatives gives us confidence that this grant will set the stage for low cost and fully scalable CAR-T manufacturing in Qatar and the Middle East." said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex. ScaleReady's G-Rex Grant Program has now surpassed $40M of no-cost product commitments to grant recipients with the goal of advancing the state of cell and gene-modified cell therapy (CGT) development and manufacturing. Individual Grant Awards are worth up to $300,000. G-Rex Grant Recipients also gain access to exclusive support from ScaleReady's growing consortium of G-Rex Grant Partners who bring best-in-class tools and technologies as well as unparalleled knowledge and expertise in the areas of cGMP manufacturing, quality and regulatory affairs, CGT business operations, and more. Importantly, ScaleReady has just introduced yet another FREE program to accelerate the universal presence of highly efficient and scalable CGT manufacturing. Under this program ScaleReady has partnered with Hanson Wade to launch an event series called LEAN Cell & Gene™. All CGT entities are invited to attend and will learn how to systematically identify and eliminate waste, stabilize business operations, increase drug product quality and supply, and develop a LEAN approach to cell and gene therapy development and manufacturing. For more information about the G-Rex® Grant Program, please contact info@ For more information about LEAN Cell & Gene™, please use this link to register for the free event series. About ScaleReadyScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing. The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs. CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization. For more information about the ScaleReady G-Rex® Grant Program, please contact info@ About Wilson Wolf ManufacturingWilson Wolf ( is dedicated to simplifying cell and gene-modified cell (CGT) therapy research, process development, and manufacturing. This is being accomplished through its scalable G-Rex technology, which is used throughout the world in CGT applications ranging from basic research to commercial drug production. Wilson Wolf's mission is to create hope for cancer patients, one G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex® Bioreactors, including right-sized reagent quantities in containers that are tailored to high throughput closed-system manufacturing. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube. Contact: David Clair, Vice President, Investor Relations & Corporate About CellReady LLCCellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About Sidra Medicine Innovating Care. Transforming Lives From the heart of Qatar, Sidra Medicine, is a private, not-for-profit academic healthcare and research institution for women, children, and young people. Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare and genetic diseases. To access our specialised healthcare or international patient services, including pediatric care, women's health, and rare disease treatment or to book a consultation at one of our private clinics, please call +974 40033333 or visit our website at For more information, follow us on Facebook, Instagram, X and LinkedIn. View original content to download multimedia: SOURCE Bio-Techne Corporation
Newsweek
4 hours ago
- Newsweek
Deep-Sea Mining Threatens U.S. Security and Ocean Peace
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Invoking national security to justify private sector economic development is a tired cliché. And yet, in a troubling twist, a Canadian company is invoking U.S. national security to obtain an exclusive license from the U.S. government for a deep-sea mining venture for critical minerals in international waters—and it appears to be working. In April 2025, the Trump administration issued an executive order to greenlight deep-sea mining in international waters, signaling a possible intent to bypass international safeguards. Just days later, an application was filed—the world's first—to commercially mine the global seabed for minerals, including manganese, nickel, copper, and cobalt. These minerals are sometimes linked to defense needs, but there is little evidence that U.S. military procurement prioritizes them—or that seabed mining is necessary. U.S. sanctioned seabed mining contributes nothing to solving the real chokepoint: China's dominance in processing, not extraction. Marine biologist placing a transect and a square, for a later census of both fish and invertebrates. These image were captured on May 8,2025, in Chichiriviche de la Costa, Venezuela. Marine biologist placing a transect and a square, for a later census of both fish and invertebrates. These image were captured on May 8,2025, in Chichiriviche de la Costa, Venezuela. Getty Images Industry proposals would ship unrefined ore to overseas processors, with no domestic value added or direct supply chain benefits. The four metals targeted by would-be deep-sea miners are not subject to Chinese export controls, and the U.S. is not materially dependent on China for their raw ore. In many cases, the U.S. is a net exporter or can readily import from allies like Australia, Chile, and South Africa. There is a 50-year history of corporations attempting to access minerals on the ocean floor, with the dominant narrative shifting over time—from economic opportunity to climate necessity to national security. But invoking national security to justify deep-sea mining ignores the broader geopolitical reality: bypassing international consensus does not strengthen U.S. interests. Companies leading the push to launch deep-sea mining under a U.S. license are foreign-incorporated entities with no operational footprint—and no meaningful supply chain commitments to it. The timeline for commercial production remains uncertain and subject to indefinite delays due to technical, financial, and regulatory hurdles. Far from offering strategic value, this initiative is best understood as a speculative venture propped up by shifting political winds. Deep-sea mining is not the answer to a mineral security crisis—it's a solution to a problem that does not exist. The industry's business model not only fails to strengthen U.S. supply chains, it undermines the international legal frameworks the U.S. relies on to secure its maritime rights. This contradiction is especially stark when viewed through the lens of the United Nations Convention on the Law of the Sea (UNCLOS), the foundation of U.S. ocean diplomacy and strategic interests. The United States has long upheld most tenets of UNCLOS, benefiting from its framework even without ratifying it. In 2023, it secured sovereign rights over more than 1 million square kilometers of seabed—an area larger than Texas— coveted by Russia and Canada. Industry attempts to exploit the outdated Deep Seabed Hard Mineral Resources Act (DSHMRA) to bypass the International Seabed Authority (ISA) directly challenges these principles. France has called it "environmental piracy." Even China has denounced the move, positioning itself as a champion of multilateralism—a recognition once held by the U.S. The consequences are not hypothetical: this legal sleight of hand weakens the U.S.' extended continental shelf claims, threatens military operations that rely on legal clarity at sea, and erodes our moral authority to lead in maritime governance. A global moratorium is urgently needed, and the ISA has a critical role to play by halting exploitation licenses under its authority until robust environmental safeguards and scientific assessments are in place. While not universally binding, a moratorium would reinforce international norms, raise the political cost of going it alone, and help protect global ocean governance. The organization's council, which met in July, passed a resolution urging its legal and technical body to look at "noncompliance" with international law. What is truly at risk is the deep ocean itself—a living, carbon-storing, biodiversity-rich system we scarcely understand. A 2023 peer-reviewed study found that deep-sea mining could have a 28 percent higher climate impact than land-based sources, which are already major climate change accelerants. Even the ISA's own financial models show collapsing economic projections due to the volatility of the market for these metals—further calling into question the wisdom of risking irreparable damage to deep ocean ecosystems. Safer, cleaner, and more cost-effective alternatives—such as mineral recycling and domestic refining efforts—are gaining momentum, many with backing from the U.S. Department of Defense. If the U.S. wants to lead, it must uphold international law, not exploit its loopholes. The International Seabed Authority must hold the line, and Congress should reform DSHMRA and prevent foreign corporations from abusing U.S. law. Protecting national security means preventing ocean conflict—not accelerating it. We cannot outpace our principles. A moratorium on deep-sea mining is not a delay tactic; it's the strongest course of action—for peace, for ecosystems, and for American leadership. Randy Manner, a retired U.S. Army major general, has served as acting and deputy director of the Defense Threat Reduction Agency, where he helped safeguard nuclear weapons and materials and assisted with the neutralization of chemical munitions in Russia. Kevin Green, a retired U.S. Navy vice admiral, has served as deputy chief of naval operations and was recognized with the Navy Distinguished Service Medal and the Legion of Merit. He commanded the USS Taylor during Operation Desert Shield and later led the U.S. Naval Forces Southern Command. The views expressed in this article are the writers' own.
Yahoo
14 hours ago
- Yahoo
Canada Goose monitors US trade policy as revenue improves
This story was originally published on Retail Dive. To receive daily news and insights, subscribe to our free daily Retail Dive newsletter. Dive Brief: Canada Goose's first quarter net revenue increased 22.4% year over year to 107.8 million Canadian dollars (about $78 million at the time of publishing), per a company press release Thursday. The apparel brand's direct-to-consumer revenue jumped about 24% and wholesale grew 12%. While gross profit improved about 26% to CA$66.2 million, Canada Goose's operating loss grew nearly 64% to CA$158.7 million and net loss increased 70% to CA$125.5 million. The company did not provide forward-looking guidance. 'As we see, anything can happen at any day,' CFO Neil Bowden said on a call with analysts Thursday. 'So we're maintaining a bit of prudence around what the outlook is for the year.' Dive Insight: As the state of U.S. and Canadian trade policies continues to fluctuate, Canada Goose is steadfast in monitoring the situation. 'We continue to monitor the ongoing developments as it relates to potential new U.S. tariffs on Canadian goods as well as potential second-order impacts on the consumer,' Bowden remarked on the call. The executive reiterated that about 75% of the brand's inventory is manufactured in Canada and 'virtually all comply with the USMCA requirements, making them currently exempt from tariffs.' From a regional perspective, Canada Goose's North American revenue was up 27% in Q1 led by DTC growth. Bowden noted that stores 'led the way with double-digit DTC comp sales growth each month in the quarter.' The brand is traditionally known for its cold-weather, high-end apparel, but it's been on a journey to expand past that reputation. In its press release Thursday, Canada Goose highlighted the release of its second Snow Goose capsule collection that featured a campaign set in the summery deserts of Utah. The latest release under creative director Haider Ackermann emphasized lightweight fabrics to reimagine classic styles from the brand. 'Newness is a new theme underpinned by the new Creative Director, Haider Ackermann, (appointed on May 2024), and we think the time is right for marketing spend in conjunction with faster and more relevant as well as lifestyle product flows,' TD Cowen analysts said in a note shared with Retail Dive on Friday. Nonheavyweight product is key to improving sales productivity and competing with top-tier luxury brands, the analysts added. The sentiment is shared by Canada Goose executives. 'When you look at the apparel growth that we've seen, we're a brand that is known for warmth,' Brand and Commercial President Carrie Baker said on the call with analysts. 'And outside of winter, we're just really not known as that brand, but this campaign, the collection really challenge that perception and people responded to it.' Recommended Reading Levi's braces for effects of economic uncertainty on consumers Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
